Literature DB >> 1183733

Twenty-four-hour serum growth hormone levels in maturity-onset diabetics.

H Kjeldsen, A P Hansen, K Lundbaek.   

Abstract

Serum growth hormone, glucose, and insulin were studied every half hour during a twenty-four-hour period of "daily life" in four groups of subjects: nonobese normal subjects, obese normal subjects, nonobese maturity-onset diabetics, and obese maturity-onset diabetics. It was found that (1) serum growth horomone was uniformly low without meal- and sleep-related peaks in obese normals and diabetics. The twenty-four-hour serum growth hormone level was significantly higher in nonobese subjects than in obese subjects, in both diabetics and normals; (2) the twenty-four-hour serum growth hormone level was more fluctuating and significantly higher in nonobese diabetics than in nonobese normals; (3) there was no difference in the twenty-four-hour serum growth hormone level between obese diabetics and obese normals.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1183733     DOI: 10.2337/diab.24.11.977

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  5 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  Evidence for cardiomyopathy in familial diabetes mellitus.

Authors:  T J Regan; M M Lyons; S S Ahmed; G E Levinson; H A Oldewurtel; M R Ahmad; B Haider
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

3.  Hypothalamic control of GH secretion: pathophysiology and clinical implications.

Authors:  H J Quabbe
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

Review 4.  A reappraisal of the blood glucose homeostat which comprehensively explains the type 2 diabetes mellitus-syndrome X complex.

Authors:  Johan H Koeslag; Peter T Saunders; Elmarie Terblanche
Journal:  J Physiol       Date:  2003-04-25       Impact factor: 5.182

5.  Effect of recombinant human growth hormone treatment on insulin-like growth factor (IGF-I) levels in insulin-dependent diabetic patients.

Authors:  M I Wurzburger; G M Prelevic; P H Sönksen; M Wheeler; L Balint-Peric
Journal:  Acta Diabetol       Date:  1995-06       Impact factor: 4.280

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.